New advances in noninvasive imaging of the carotid artery: CIMT, contrast-enhanced ultrasound, and vasa vasorum

[1] Hossain P., Kawar B., El Nahas M., Obesity and diabetes in the developing world - A growing challenge, N Engl J Med, 356, pp. 213-215, (2007)

[2] Gami A.S., Witt B.J., Howard D.E., Erwin P.J., Gami L.A., Somers V.K., Montori V.M., Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death. A Systematic Review and Meta-Analysis of Longitudinal Studies, Journal of the American College of Cardiology, 49, 4, pp. 403-414, (2007)

[3] Cowie C.C., Rust K.F., Byrd-Holt D.D., Eberhardt M.S., Flegal K.M., Engelgau M.M., Saydah S.H., Williams D.E., Geiss L.S., Gregg E.W., Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999-2002, Diabetes Care, 29, 6, pp. 1263-1268, (2006)

[4] Lorenz M.W., Markus H.S., Bots M.L., Rosvall M., Sitzer M., Prediction of clinical cardiovascular events with carotid intima-media thickness: A systematic review and meta-analysis, Circulation, 115, 4, pp. 459-467, (2007)

[5] Casscells W., Naghavi M., Willerson J.T., Vulnerable atherosclerotic plaque: A multifocal disease, Circulation, 107, 16, pp. 2072-2075, (2003)

[6] Naghavi M., Falk E., Hecht H.S., Jamieson M.J., Kaul S., Berman D., Fayad Z., Budoff M.J., Rumberger J., Naqvi T.Z., Shaw L.J., Faergeman O., Cohn J., Bahr R., Koenig W., Demirovic J., Arking D., Herrera V.L.M., Badimon J., Goldstein J.A., Rudy Y., Airaksinen J., Schwartz R.S., Riley W.A., Mendes R.A., Douglas P., Shah P.K., From Vulnerable Plaque to Vulnerable Patient-Part III: Executive Summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force Report, American Jour

[7] Khot U.N., Khot M.B., Bajzer C.T., Sapp S.K., Ohman E.M., Brener S.J., Ellis S.G., Lincoff A.M., Topol E.J., Prevalence of Conventional Risk Factors in Patients with Coronary Heart Disease, Journal of the American Medical Association, 290, 7, pp. 898-904, (2003)

[8] Espeland M.A., O'Leary D.H., Terry J.G., Morgan T., Evans G., Mudra H., Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors, Current Controlled Trials in Cardiovascular Medicine, 6, (2005)

[9] Hurst R.T., Ng D.W.C., Kendall C., Khandheria B., Clinical Use of Carotid Intima-Media Thickness: Review of the Literature, Journal of the American Society of Echocardiography, 20, 7, pp. 907-914, (2007)

[10] Pignoli P., Longo T., Ultrasound evaluation of atherosclerosis. Methodological problems and technological developments, Eur Surg Res, 18, pp. 238-253, (1986)

[1] Hossain P., Kawar B., El Nahas M., Obesity and diabetes in the developing world - A growing challenge, N Engl J Med, 356, pp. 213-215, (2007)

[2] Gami A.S., Witt B.J., Howard D.E., Erwin P.J., Gami L.A., Somers V.K., Montori V.M., Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death. A Systematic Review and Meta-Analysis of Longitudinal Studies, Journal of the American College of Cardiology, 49, 4, pp. 403-414, (2007)

[3] Cowie C.C., Rust K.F., Byrd-Holt D.D., Eberhardt M.S., Flegal K.M., Engelgau M.M., Saydah S.H., Williams D.E., Geiss L.S., Gregg E.W., Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999-2002, Diabetes Care, 29, 6, pp. 1263-1268, (2006)

[4] Lorenz M.W., Markus H.S., Bots M.L., Rosvall M., Sitzer M., Prediction of clinical cardiovascular events with carotid intima-media thickness: A systematic review and meta-analysis, Circulation, 115, 4, pp. 459-467, (2007)

[5] Casscells W., Naghavi M., Willerson J.T., Vulnerable atherosclerotic plaque: A multifocal disease, Circulation, 107, 16, pp. 2072-2075, (2003)

[6] Naghavi M., Falk E., Hecht H.S., Jamieson M.J., Kaul S., Berman D., Fayad Z., Budoff M.J., Rumberger J., Naqvi T.Z., Shaw L.J., Faergeman O., Cohn J., Bahr R., Koenig W., Demirovic J., Arking D., Herrera V.L.M., Badimon J., Goldstein J.A., Rudy Y., Airaksinen J., Schwartz R.S., Riley W.A., Mendes R.A., Douglas P., Shah P.K., From Vulnerable Plaque to Vulnerable Patient-Part III: Executive Summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force Report, American Jour

[7] Khot U.N., Khot M.B., Bajzer C.T., Sapp S.K., Ohman E.M., Brener S.J., Ellis S.G., Lincoff A.M., Topol E.J., Prevalence of Conventional Risk Factors in Patients with Coronary Heart Disease, Journal of the American Medical Association, 290, 7, pp. 898-904, (2003)

[8] Espeland M.A., O'Leary D.H., Terry J.G., Morgan T., Evans G., Mudra H., Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors, Current Controlled Trials in Cardiovascular Medicine, 6, (2005)

[9] Hurst R.T., Ng D.W.C., Kendall C., Khandheria B., Clinical Use of Carotid Intima-Media Thickness: Review of the Literature, Journal of the American Society of Echocardiography, 20, 7, pp. 907-914, (2007)

[10] Pignoli P., Longo T., Ultrasound evaluation of atherosclerosis. Methodological problems and technological developments, Eur Surg Res, 18, pp. 238-253, (1986)